PFE – pfizer, inc. (US:NASDAQ)

News

U.S. FDA Approves Pfizer's BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer [Yahoo! Finance]
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
Is Pfizer (PFE) a Cheap NYSE Stock to Invest in Now? [Yahoo! Finance]
Why Pfizer (PFE) Dipped More Than Broader Market Today [Yahoo! Finance]
GoComet's Odyssey Singapore 2024 Highlights: When Supply Chain Giants Meet
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com